General description
3-Hydroxyphenazepam is an active metabolite of the novel psychoactive benzodiazepine phenazepam, which emerged in online drug markets in late 2011. Despite being a controlled substance in Europe, North America, and many countries in Asia, phenazepam has been encountered in the form of LSD mimic blotters and as counterfeit diazepam. This certified Snap-N-Spike® solution is suitable for use as a starting material in calibrators and controls for numerous GC/MS or LC/MS applications in forensic analysis, clinical toxicology and urine drug testing.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Molecular Weight: 365.61. Empirical Formula: C15H10BrClN2O2. grade: certified reference material. Quality Level: 300. form: liquid. feature: Snap-N-Spike®. /Snap-N-Shoot®. . packaging: ampule of 1 . mL. manufacturer/tradename: Cerilliant®. . concentration: 1.0 . mg/mL in acetonitrile. technique(s): gas chromatography (GC): suitable, liquid chromatography (LC): suitable. application(s): clinical testing. format: single component solution. storage temp.: −. 20°C. SMILES string: BrC1: CC(C(C2: CC: CC: C2Cl): NC3O): C(C: C1)NC3: O. InChI: 1S/C15H10BrClN2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20). InChI key: KRJKJUWAZOWXNV-UHFFFAOYSA-N. Pictograms: GHS02,GHS07. Signal Word: Danger. Hazard Statements: H225 - H302 + H312 + H332 - H319 - H412. Precautionary Statements: P210 - P273 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312. Hazard Classifications: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Irrit. 2 - Flam. Liq. 2. Storage Class Code: 3 - Flammable liquids. WGK: WGK 2. Flash Point(F): 35.6 °F - closed cup. Flash Point(C): 2.0 °C - closed cup.- UPC:
- 51191503
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- H-113-1ML
- CAS:
- 70030-11-4
akash.verma@cenmed.com
(732) 447-1115





